Development of Gallic Acid-loaded Liposomes to Combat Non-alcoholic Steatohepatitis
Background: This research explores the development of a novel herbal-targeted therapy leveraging Gallic Acid (GA), a polyphenolic phytoconstituent abundant in plants such as tea, grapes, and gallnuts, renowned for its potent anti-inflammatory, antioxidant, and lipid-modulating properties. Targeting the liver is of critical importance in Non-Alcoholic Steatohepatitis (NASH) therapy. A novel drug delivery approach, biocompatible and biodegradable vesicular carriers capable of improving drug stability, drug permeability, and targeted delivery to hepatic cells. Aim: To develop and optimise gallic acid-loaded liposomal formulations using thinfilm hydration and investigate the influence of formulation variables (lipid concentration, sonication time) on particle size and encapsulation of gallic acid liposomes using a Box–Behnken design, characterise their physicochemical properties and evaluate in vitro release kinetics with controlled Higuchi diffusion-controlled release for potential therapy of NASH. Methods: The study involves the formulation and optimisation of gallic acid-loaded liposomes using techniques such as thin-film hydration and the Box-Behnken design to achieve optimal particle size. Results: The optimised formulation exhibited an average particle size of approximately 2.7 μm with a drug encapsulation efficiency of 80% after a Fourier Transform Infrared Spectroscopy (FTIR) study of pure gallic acid. The Higuchi model showed the highest R 2 value (0.982); the drug release follows the Higuchi diffusion-controlled release mechanism. Conclusion: This research aims to prepare and evaluate a Gallic acid-loaded liposome formulation, perform physicochemical characterisation, and assess in vitro dissolution to ensure enhanced delivery and therapeutic performance Major Findings: Y=b 0 + 0.753A + 0.223C; according to this equation, where y is particle size(μm), and b 0 , the y-intercept, is 0.024, the optimised gallic acid-loaded drug indicates tha